Publications

  1. Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD 2nd, Houghton DE. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc. 2021 Jul; 96 (7):1718-1726 Epub 2021 May 04
    View PubMed
  2. Riaz IB, Fuentes HE, Ahmed Naqvi SA, He H, Riaz Sipra QU, Tafur AJ, Padranos L, Wysokinski WE, Marshall AL, Vandvik PO, Montori V, Bryce AH, Liu H, Badgett RG, Murad MH, McBane RD 2nd. TEMPORARY REMOVAL: Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis. Mayo Clin Proc. 2021 Jun 22 Epub 2021 June 22
    View PubMed
  3. Houghton DE, Ashrani A, Liedl D, Mehta RA, Hodge DO, Rooke T, Wennberg P, Wysokinski W, McBane R. Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study. Blood. 2021 Jun 10; 137 (23):3284-3290
    View PubMed
  4. Vlazny DT, Pasha AK, Kuczmik W, Wysokinski WE, Bartlett M, Houghton D, Casanegra AI, Daniels P, Froehling DA, White LJ, Hodge DO, McBane RD 2nd. Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis. J Thromb Haemost. 2021 Jun 1 Epub 2021 June 01
    View PubMed
  5. Brunton NE, Wysokinski WE, Hodge DO, Vlazny DT, Houghton DE, Casanegra AI. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes. Res Pract Thromb Haemost. 2021 May; 5 (4):e12500 Epub 2021 Apr 07
    View PubMed
  6. Kuczmik W, Wysokinski WE, Macedo T, Froehling D, Daniels P, Casanegra A, Houghton D, Vlazny D, Meverden R, Lang T, White L, Hodge D, McBane RD 2nd. Calf Vein Thrombosis Outcomes Comparing Anticoagulation and Serial Ultrasound Imaging Management Strategies. Mayo Clin Proc. 2021 May; 96 (5):1184-1192 Epub 2021 Apr 09
    View PubMed
  7. Pasha AK, Kuczmik W, Wysokinski WE, Casanegra AI, Houghton D, Vlazny DT, Mertzig A, Hirao-Try Y, White L, Hodge D, McBane Ii R. Calf vein thrombosis outcomes comparing patients with and without cancer. J Thromb Thrombolysis. 2021 May; 51 (4):1059-1066 Epub 2021 Feb 04
    View PubMed
  8. Henkin S, McBane RD 2nd, Rooke TW, Wysokinski WE, Casanegra AI, Liedl DA, Wennberg PW. Major adverse events associated with inducible cardiac ischemia during treadmill exercise testing for peripheral artery disease. J Vasc Surg. 2021 Apr 19 [Epub ahead of print]
    View PubMed
  9. Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd. Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):388-402 Epub 2021 Feb 08
    View PubMed
  10. Melduni R, Nkomo VT, Wysokinski W, Gersh BJ, Deshmukh A, Padang R, Greene EL, Oh JK, Lee HC. Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation. Heart. 2021 Mar 25 [Epub ahead of print]
    View PubMed
  11. Wysokinski WE, Melduni RM, Ammash NM, Vlazny DT, Konik E, Saadiq RA, Gosk-Bierska I, Slusser J, Grill D, McBane RD. Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation. CJC Open. 2021 Mar; 3 (3):318-326 Epub 2020 Nov 13
    View PubMed
  12. Henkin S, Wysokinski WE, Tweet M, Shamoun F, Naidu S, Sutkowska K, Bator K, Shields R, Greene E, Keller S, Hodge D, McBane R 2nd. Spontaneous visceral artery dissections in otherwise normal arteries: Clinical features, management, and outcomes compared with fibromuscular dysplasia. J Vasc Surg. 2021 Feb; 73 (2):516-523.e2 Epub 2020 July 02
    View PubMed
  13. Kuczmik W, Wysokinski WE, Hesley GK, Vlazny DT, Houghton DE, Swanson KE, Casanegra AI, Hodge D, White L, McBane RD 2nd. Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis. Thromb Haemost. 2021 Feb; 121 (2):216-223 Epub 2020 Aug 22
    View PubMed
  14. Halkar M, Medina Inojosa J, Liedl D, Wysokinski W, Houghton DE, Wennberg PW, Lin G, Kane G, Fischer K, Rooke TW, Saadiq R, Bonikowske A, McBane RD 2nd. Calf muscle pump function as a predictor of all-cause mortality. Vasc Med. 2020 Dec; 25 (6):519-526 Epub 2020 Sept 25
    View PubMed
  15. McBane RD 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, Casanegra AI, Oyen LJ, Houghton DE, Marshall AL, Ou NN, Siegel JL, Wysokinski WE, Padrnos LJ, Rivera CE, Flo GL, Shamoun FE, Silvers SM, Nayfeh T, Urtecho M, Shah S, Benkhadra R, Saadi SM, Firwana M, Jawaid T, Amin M, Prokop LJ, Murad MH. Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc. 2020 Nov; 95 (11):2467-2486 Epub 2020 Aug 31
    View PubMed
  16. Wysokinski WE, Froehling DA, Houghton DE, McBane RD, Vlazny DT, Bott-Kitslaar DM, Kuczmik W, Sutkowska K, Bator K, Hodge DO, Peterson LG, Casanegra AI. Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight. Eur J Haematol. 2020 Oct; 105 (4):484-494 Epub 2020 July 27
    View PubMed
  17. van Zyl M, Wysokinski WE, Jaeger TM, Casanegra AI, Gersh BJ, McBane RD 2nd. In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4 (5):511-520 Epub 2020 Aug 15
    View PubMed
  18. Patlolla SH, Lee HC, Noseworthy PA, Wysokinski WE, Hodge DO, Greene EL, Gersh BJ, Melduni RM. Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation. Am J Cardiol. 2020 Sep 15; 131:33-39 Epub 2020 June 30
    View PubMed
  19. Chaudhary R, Pagali S, Garg J, Murad MH, Wysokinski WE, McBane RD 2nd. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2020 Sep; 68 (9):2021-2026 Epub 2020 May 22
    View PubMed
  20. Houghton DE, Casanegra AI, Peterson L, Cochuyt J, Hodge DO, Vlazny D, McBane RD, Froehling D, Wysokinski WE. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban. Am J Hematol. 2020 Jul; 95 (7):817-823 Epub 2020 Apr 20
    View PubMed
  21. Cambron JC, Saba ES, McBane RD, Casanegra AI, Villarraga HR, Houghton DE, Vlazny DT, Froehling D, Hodge D, Peterson LG, Bott-Kitslaar DM, Wysokinski WE. Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism. Mayo Clin Proc Innov Qual Outcomes. 2020 Jun; 4 (3):249-258 Epub 2020 June 05
    View PubMed
  22. Chaudhary Rahul, Pagali Sandeep, Garg Jalaj, Wysokinski Waldemar E., McBane Robert D. II. Safety and Efficacy of Direct Oral Anticoagulants in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-analysis Journal of American Geriatric Society. 2020.
  23. Houghton DE, Lekah A, Macedo TA, Hodge D, Saadiq RA, Little Y, Casanegra AI, McBane RD, Wysokinski WE. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin. J Thromb Thrombolysis. 2020 Feb; 49 (2):199-205
    View PubMed
  24. McBane RD 2nd, Loprinzi CL, Ashrani A, Lenz CJ, Houghton D, Zemla T, Le-Rademacher JG, Wysokinski WE. Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial. Eur J Haematol. 2020 Feb; 104 (2):88-96 Epub 2019 Nov 11
    View PubMed
  25. McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, Zemla T, Ashrani A, Tafur A, Perepu U, Anderson D, Gundabolu K, Kuzma C, Perez Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Houghton DE, Vishnu P, Loprinzi CL. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemost. 2020 Feb; 18 (2):411-421 Epub 2019 Nov 28
    View PubMed
  26. Melduni RM, Wysokinski WE, Wang Z, Gersh BJ, Asirvatham SJ, Patlolla SH, Greene EL, Oh JK, Lee HC. Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation. Open Heart. 2020; 7 (1):e001229 Epub 2020 Apr 06
    View PubMed
  27. Fuentes HE, McBane RD 2nd, Wysokinski WE, Tafur AJ, Loprinzi CL, Murad MH, Riaz IB. Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis. Mayo Clin Proc. 2019 Dec; 94 (12):2444-2454 Epub 2019 Nov 02
    View PubMed
  28. Wysokinski WE, Houghton DE, Casanegra AI, Vlazny DT, Bott-Kitslaar DM, Froehling DA, Hodge DO, Peterson LG, Mcbane RD. Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism. Am J Hematol. 2019 Nov; 94 (11):1185-1192 Epub 2019 Aug 19
    View PubMed
  29. Bott-Kitslaar DM, McBane RD, Casanegra AI, Houghton DE, Froehling DA, Vlazny DT, Ashrani AA, Hodge DO, Vargas ER, Bartlett MA, Saadiq RA, Daniels PR, Shields RC, Lenz CJ, Lang TR, Wysokinski WE. Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism. Mayo Clin Proc. 2019 Jul; 94 (7):1242-1252 Epub 2019 Feb 06
    View PubMed
  30. Wysokinski WE, Cohoon KP, Melduni RM, Mazur M, Ammash N, Munger T, Konik E, McLeod T, Gosk-Bierska I, McBane RD. Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation. Thromb Res. 2018 Dec; 172:4-8 Epub 2018 Oct 10
    View PubMed
  31. Mimier MK, Janczak DT, McBane RD, Houghton DE, Wysokinski WE. Thrombosis of atypical location: how to treat patients in the era of direct oral anticoagulants? Pol Arch Intern Med. 2018 Oct 31; 128 (10):604-608 Epub 2018 Sept 20
    View PubMed
  32. Melduni RM, Gersh BJ, Wysokinski WE, Ammash NM, Friedman PA, Hodge DO, Chandrasekaran K, Oh JK, Lee HC. Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation. Am J Cardiol. 2018 Jun 15; 121 (12):1540-1547 Epub 2018 Mar 13
    View PubMed
  33. Simmons B, Wysokinski W, Saadiq RA, Bott-Kitslaar D, Henkin S, Casanegra A, Lenz C, Daniels P, Bjarnason H, Vargas E, Hodge D, Holton SJ, Cerhan JR, Loprinzi C, McBane R 2nd. Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolism. Eur J Haematol. 2018 Apr 4 Epub 2018 Apr 04
    View PubMed
  34. Lenz CJ, Wysokinski WE, McBane RD. In Reply. Obstet Gynecol 2018 Apr; 131 (4):741-742
    View PubMed
  35. Konik E, Anavekar NS, Wysokinski W, Chandrasekaran K. Submassive Pulmonary Embolism and Left Atrial Thrombus. CASE (Phila). 2018 Apr; 2 (2):51-53 Epub 2018 Feb 14
    View PubMed
  36. Wysokinski WE, Tafur A, Wu Y, Ammash N, Asirvatham SJ, Gosk-Bierska I, Grill DE, Slusser JP, Mruk J, McBane RD. Platelet-predominate gene expression and reticulated platelets in nonvalvular atrial fibrillation: Effect of pulmonary veins isolation. J Cardiovasc Electrophysiol. 2018 Mar; 29 (3):412-420 Epub 2018 Feb 13
    View PubMed
  37. Joppa SA, Salciccioli J, Adamski J, Patel S, Wysokinski W, McBane R, Al-Saffar F, Esser H, Shamoun F. A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents. J Clin Med. 2018 Feb 11; 7 (2)
    View PubMed
  38. Janczak DT, Mimier MK, McBane RD, Kamath PS, Simmons BS, Bott-Kitslaar DM, Lenz CJ, Vargas ER, Hodge DO, Wysokinski WE. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location. Mayo Clin Proc. 2018 Jan; 93 (1):40-47 Epub 2017 Dec 06
    View PubMed
  39. Lenz CJ, McBane RD, Cohoon KP, Janczak DT, Simmons BS, Saadiq RA, Mimier M, Casanegra AI, Daniels PR, Wysokinski WE. Testicular vein thrombosis: Incidence of recurrent venous thromboembolism and survival. Eur J Haematol. 2018 Jan; 100 (1):83-87 Epub 2017 Nov 13
    View PubMed
  40. Wysokinski WE, Cohoon KP, Konik EA, Melduni RM, Ammash NM, Asirvatham SJ, McBane RD. Effect of atrial fibrillation duration on plasma von Willebrand factor level. Eur J Haematol. 2017 Dec; 99 (6):569-576 Epub 2017 Oct 16
    View PubMed
  41. Lenz CJ, Wysokinski WE, Henkin S, Cohoon KP, Casanegra A, Simmons BS, Saadiq RA, Daniels PR, Wysokinska EM, Bjarnason H, McBane RD. Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival. Obstet Gynecol. 2017 Nov; 130 (5):1127-1135
    View PubMed
  42. McBane RD, McBane Ii R, Loprinzi CL, Ashrani A, Perez-Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Le-Rademacher JG, Wysokinski WE. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial. Thromb Haemost. 2017 Oct 5; 117 (10):1952-1961 Epub 2017 Aug 24
    View PubMed
  43. Wysokinski WE, Tafur A, Ammash N, Asirvatham SJ, Wu Y, Gosk-Bierska I, Grill DE, Slusser JP, Mruk J, McBane RD. Impact of atrial fibrillation on platelet gene expression. Eur J Haematol. 2017 Jun; 98 (6):615-621 Epub 2017 Apr 20
    View PubMed
  44. Melduni RM, Schaff HV, Lee HC, Gersh BJ, Noseworthy PA, Bailey KR, Ammash NM, Cha SS, Fatema K, Wysokinski WE, Seward JB, Packer DL, Rihal CS, Asirvatham SJ. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients. Circulation. 2017 Jan 24; 135 (4):366-378 Epub 2016 Nov 30
    View PubMed
  45. Cohoon KP, Mazur M, McBane RD, Ammash N, Asirvatham SJ, Wysokinski WE. Association of Soluble CD40 Ligand With Duration of Atrial Fibrillation and With Intensity of Spontaneous Echocardiographic Contrast. JACC Clin Electrophysiol. 2016 Oct; 2 (5):623-632 Epub 2016 May 25
    View PubMed
  46. Wysokinska EM, Wysokinski WE, Ketha S, Litin S, Daniels P, Slusser J, Hodge DO, Heit JA, McBane RD 2nd. Periprocedural Anticoagulation Management of Patients with Thrombophilia. Am J Med. 2016 Sep; 129 (9):986-92 Epub 2016 May 24
    View PubMed
  47. Bott-Kitslaar DM, Saadiq RA, McBane RD, Loprinzi CL, Ashrani AA, Ransone TR, Wolfgram AA, Berentsen MM, Wysokinski WE. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry. Am J Med. 2016 Jun; 129 (6):615-9 Epub 2016 Jan 18
    View PubMed
  48. Cohoon KP, McBane RD, Ammash N, Slusser JP, Grill DE, Wysokinski WE. Relationship between body mass index and left atrial appendage thrombus in nonvalvular atrial fibrillation. J Thromb Thrombolysis. 2016 May; 41 (4):613-8
    View PubMed
  49. Perez Botero J, Ormsby WD, Ashrani AA, McBane RD 2nd, Wysokinski WE, Patnaik MM, Lewis BR, Grill DE, Pruthi RK, Heit JA. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study. Eur J Intern Med. 2016 May; 30:77-81.
    View PubMed
  50. Little Y, McBane RD, Wysokinski WE. Images in Vascular Medicine. Leukemia cutis imitating venous ulcerations. Vasc Med. 2016 Apr; 21: (2)172-3.
    View PubMed
  51. Sridharan M, Wysokinski WE, Pruthi R, Oyen L, Freeman WD, Rabinstein AA, McBane RD. Periprocedural warfarin reversal with prothrombin complex concentrate. Thromb Res. 2016 Mar; 139:160-5.
    View PubMed
  52. Schaefer JK, McBane RD, Wysokinski WE. How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation. Ann Hematol. 2016 Feb; 95 (3):437-49 Epub 2015 Dec 11
    View PubMed
  53. Gosk-Bierska I, Wasilewska M, Wysokinski W. Role of Platelets in Thromboembolism in Patients with Atrial Fibrillation. Adv Clin Exp Med. 2016 Jan-Feb; 25 (1):163-71
    View PubMed
  54. Tafur AJ, McBane RD, Ammash N, Asirvatham SJ, Miller RD, Janczak D, Slusser JP, Grill DE, Whelan SL, Wysokinski WE. Impact of Atrial Fibrillation and Sinus Rhythm Restoration on Reticulated Platelets. Mayo Clin Proc. 2015 Dec; 90: (12)1650-8.
    View PubMed
  55. Brown SA, Doolittle DA, Bohanon CJ, Jayaraj A, Naidu SG, Huettl EA, Renfree KJ, Oderich GS, Bjarnason H, Gloviczki P, Wysokinski WE, McPhail IR. Quadrilateral space syndrome: the Mayo Clinic experience with a new classification system and case series. Mayo Clin Proc. 2015 Mar; 90(3):382-94. Epub 2015 Jan 31.
    View PubMed
  56. Cohoon KP, Mazur M, McBane RD, Ketha S, Ammash N, Wysokinski WE. The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation. Int J Cardiol. 2015 Feb 15; 181:207-12 Epub 2014 Dec 03
    View PubMed
  57. Blustin JM, McBane RD, Mazur M, Ammash N, Sochor O, Grill DE, Wysokinski WE. The association between thromboembolic complications and blood group in patients with atrial fibrillation. Mayo Clin Proc. 2015 Feb; 90(2):216-23.
    View PubMed
  58. Schaefer JK, McBane RD, Black DF, Williams LN, Moder KG, Wysokinski WE. Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thromb Haemost. 2014 Nov; 112(5):947-50. Epub 2014 Aug 14.
    View PubMed
  59. Kitslaar DB, Wysokinski WE, McBane RD 2nd. The role of novel anticoagulants in the management of venous thromboembolic disease. Curr Treat Options Cardiovasc Med. 2014 Aug; 16 (8):326
    View PubMed
  60. Ketha SS, Pruthi RK, McBane RD, Wysokinski WE. Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation. J Thromb Thrombolysis. 2014 May; 37 (4):532-5
    View PubMed
  61. Cassar A, Barsness GW, Wysokinski WE, Gifford SM, Bower TC, Edwards WD, Gulati R. Pneumatic compression for embolic protection during upper extremity endovascular intervention. Vasc Endovascular Surg. 2014 Jan; 48: (1)70-3.
    View PubMed
  62. McBane RD 2nd, Gonzalez C, Hodge DO, Wysokinski WE. Propensity for young reticulated platelet recruitment into arterial thrombi. J Thromb Thrombolysis. 2014; 37 (2):148-54
    View PubMed
  63. McBane RD 2nd, Karnicki K, Wysokinski WE. Platelet recruitment to venous stent thrombi. J Thromb Thrombolysis. 2013 Nov; 36 (4):442-7
    View PubMed
  64. Attaya H, Shah ND, Wysokinski WE, Van Houten HK, Heit JA, McBane RD 2nd. Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Int J Cardiol. 2013 Oct 15; 168 (6):5311-5 Epub 2013 Aug 15
    View PubMed
  65. Sutkowska E, McBane RD, Tafur AJ, Sutkowski K, Grill DE, Slusser JP, Wysokinski WE. Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America. J Gastroenterol. 2013 Oct; 48(10):1111-8. Epub 2012 Dec 18.
    View PubMed
  66. Ketha S, Smithedajkul P, Vella A, Pruthi R, Wysokinski W, McBane R. Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost. 2013 Apr; 109(4):669-75. Epub 2013 Feb 07.
    View PubMed
  67. Attaya H, Wysokinski WE, Bower T, Litin S, Daniels PR, Slusser J, Heit JA, McBane RD 2nd. Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients. J Thromb Thrombolysis. 2013 Jan; 35 (1):100-6
    View PubMed
  68. Golovyan D, Wysokinski W, McBane RD 2nd. Septic venous thromboembolism. Vasc Med. 2012 Dec; 17: (6)429-30.
    View PubMed
  69. Tafur AJ, Wysokinski WE, McBane RD, Wolny E, Sutkowska E, Litin SC, Daniels PR, Slusser JP, Hodge DO, Heit JA. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients. Ann Oncol. 2012 Aug; 23 (8):1998-2005 Epub 2012 Apr 03
    View PubMed
  70. Kurklinsky AK, Bjarnason H, Friese JL, Wysokinski WE, McBane RD, Misselt A, Moller SM, Gloviczki P. Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol. 2012 Aug; 23 (8):1009-15 Epub 2012 June 13
    View PubMed
  71. Tafur AJ, Wysokinski WE, McBane RD, Wolny E, Sutkowska E, Litin SC, Daniels PR, Slusser JP, Hodge DO, Heit JA. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients. Ann Oncol. 2012 Aug; 23 (8):1998-2005 Epub 2019 Dec 04
    View PubMed
  72. Wysokinski WE, McBane RD 2nd. Periprocedural bridging management of anticoagulation. Circulation. 2012 Jul 24; 126(4):486-90.
    View PubMed
  73. Skeik N, Kalsi H, Wysokinski WE, Heaser TV, Wennberg PW. Predicting superficial venous incompetence with strain gauge plethysmography. Phlebology. 2012 Apr; 27: (3)135-40.
    View PubMed
  74. Tafur AJ, McBane R 2nd, Wysokinski WE, Litin S, Daniels P, Slusser J, Hodge D, Beckman MG, Heit JA. Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost. 2012 Feb; 10(2):261-7.
    View PubMed
  75. Tafur AJ, McBane RD II, Wysokinski WE, Gregg MS, Daniels PR, Mohr DN. Natural language processor as a tool to assess heparin induced thrombocytopenia awareness. J Thromb Thrombolysis. 2012 Jan; 33(1):95-100.
    View PubMed
  76. Ammash N, Konik EA, McBane RD, Chen D, Tange JI, Grill DE, Herges RM, McLeod TG, Friedman PA, Wysokinski WE. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation. Arterioscler Thromb Vasc Biol. 2011 Nov; 31: (11)2760-6.
    View PubMed
  77. Gosk-Bierska I, McBane RD, Wu Y, Mruk J, Tafur A, McLeod T, Wysokinski WE. Platelet factor XIII gene expression and embolic propensity in atrial fibrillation. Thromb Haemost. 2011 Jul; 106: (1)75-82.
    View PubMed
  78. Kurklinsky AK, Kalsi H, Wysokinski WE, Mauck KF, Bhagra A, Havyer RD, Thompson CA, Hayes SN, McBane RD 2nd. Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume. Angiology. 2011 Apr; 62: (3)253-6.
    View PubMed
  79. Tafur A, McBane R II, Wysokinski WE. Usefulness of heparin as bridging anticoagulation therapy in atrial fibrillation. Salud(i)Ciencia. 2011; 18(2):117-22.
  80. Tafur AJ, Kalsi H, Wysokinski WE, McBane RD, Ashrani AA, Marks RS, Crusan DJ, Petterson TM, Bailey KR, Heit JA. The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc. 2011 Jan; 86 (1):25-30
    View PubMed
  81. Wysokinska EM, Sobande F, Wysokinski WE, Bjarnason H, McBane Ii RD. Iliac vein thrombosis: feasibility assessment of randomized controlled trials of endovascular pharmacomechanical thrombolysis. J Thromb Haemost. 2010 Sep; 8 (9):1943-9
    View PubMed
  82. Tafur A, Wysokinski W, Vrtiska T, McBane R 2nd. Budd-Chiari syndrome, mediastinal mass and recalcitrant leg ulcers, an unlikely trio. J Thromb Thrombolysis. 2010 Aug; 30 (2):226-8
    View PubMed
  83. McBane RD 2nd, Tafur A, Wysokinski WE. Acquired and congenital risk factors associated with cerebral venous sinus thrombosis. Thromb Res. 2010 Aug; 126(2):81-7. Epub 2010 Jun 11.
    View PubMed
  84. Palamari B, Breen JF, Wysokinski WE. Lipoma causing upper extremity deep vein thrombosis: a case report. J Thromb Thrombolysis. 2010 Jul; 30 (1):109-11 Epub 2009 Aug 29
    View PubMed
  85. Wysokinski WE, Ammash N, Sobande F, Kalsi H, Hodge D, McBane RD. Predicting left atrial thrombi in atrial fibrillation. Am Heart J. 2010 Apr; 159: (4)665-71.
    View PubMed
  86. McBane RD, Wysokinski WE, Daniels PR, Litin SC, Slusser J, Hodge DO, Dowling NF, Heit JA. Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol. 2010 Mar; 30(3):442-8. Epub 2010 Feb 05.
    View PubMed
  87. Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):200-5. Epub 2009 Sep 25.
    View PubMed
  88. Sutkowska E, Wozniewski M, Gamian A, Gosk-Bierska I, Alexewicz P, Sutkowski K, Wysokinski WE. Intermittent pneumatic compression in stable claudicants: effect on hemostasis and endothelial function. Int Angiol. 2009 Oct; 28(5):373-9.
    View PubMed
  89. Obi C, Wysokinski W, Karnicki K, Owen WG, McBane RD 2nd. Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy. Arterioscler Thromb Vasc Biol. 2009 Sep; 29(9):1271-6. Epub 2009 Aug 10.
    View PubMed
  90. Wysokinski WE, McBane RD, Daniels PR, Litin SC, Hodge DO, Dowling NF, Heit JA. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc. 2008 Jun; 83(6):639-45.
    View PubMed
  91. McBane RD, Hodge DO, Wysokinski WE. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. Thromb Haemost. 2008 May; 99: (5)951-5.
    View PubMed
  92. McBane RD 2nd, Wysokinski WE. Treatment of venous thrombosis at unusual sites. Curr Treat Options Cardiovasc Med. 2008 Apr; 10 (2):136-45
    View PubMed
  93. Karnicki K, Leadley RJ Jr, Baxi S, Peterson T, Wysokinski W, McBane RD 2nd. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis. Thromb Haemost. 2008 Apr; 99 (4):759-66
    View PubMed
  94. McBane RD 2nd, Leadley RJ Jr, Baxi SM, Karnicki K, Wysokinski W. Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs. Arterioscler Thromb Vasc Biol. 2008 Mar; 28 (3):413-8 Epub 2007 Dec 20
    View PubMed
  95. Davis MD, Wysokinski WE. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin. J Am Acad Dermatol. 2008 Mar; 58(3):512-5.
    View PubMed
  96. Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, McBane RD 2nd. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology. 2008 Feb 19; 70 (8):627-33
    View PubMed
  97. Wysokinski WE, Gosk-Bierska I, Greene EL, Grill D, Wiste H, McBane RD 2nd. Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis. 2008 Feb; 51(2):224-32.
    View PubMed
  98. Smyth SS, Monroe DM 3rd, Wysokinski WE, McBane RD 2nd, Whiteheart SW, Becker RC, Steinhubl SR. Platelet activation and its patient-specific consequences. Thromb Res. 2008; 122(4):435-41. Epub 2007 Oct 22.
    View PubMed
  99. Wysokinski W, Karnicki K, McBane RD 2nd. Individual propensity for thrombosis: comparison of venous and arterial circulations. Thromb Res. 2008; 122: (3)390-6.
    View PubMed
  100. Thatipelli MR, Pellikka PA, McBane RD, Rooke TW, Rosales GA, Hodge D, Herges RM, Wysokinski WE. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg. 2007 Jul; 46 (1):62-70; discussion 70 Epub 2007 June 20
    View PubMed
  101. Gosk-Bierska I, McBane RD, Waszczuk E, Paradowski L, Wysokinski WE. Prevalence of lower extremity venous disease in inflammatory bowel disease. Int Angiol. 2007 Mar; 26(1):67-71.
    View PubMed
  102. McBane RD 2nd, Gloviczki P, Wysokinski WE. Images in vascular medicine. Cross-clamp injury: an unusual cause of intermittent claudication. Vasc Med. 2006 Nov; 11: (3)173-4.
    View PubMed
  103. Burches B, Karnicki K, Wysokinski W, McBane RD. Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis. Thromb Haemost. 2006 Nov; 96(5):618-22.
    View PubMed
  104. Gosk-Bierska I, Wysokinski W, Brown RD Jr, Karnicki K, Grill D, Wiste H, Wysokinska E, McBane RD 2nd. Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology. 2006 Sep 12; 67 (5):814-9
    View PubMed
  105. Wysokinski WE, Gosk-Bierska I, Karnicki K, McBane RD II. Renal vein thrombosis - Etiology, diagnosis, therapeutic options. Advances in Clinical and Experimental Medicine. 2006; 15(5):917-24.
  106. Gosk-Bierska I, Wysokinski W, Adamiec R. Plasmin-alpha2-antiplasmin complexes in non-diabetic and diabetic patients with peripheral arterial occlusive disease. [Polish]. Advances in Clinical and Experimental Medicine. 2006; 15(1):67-74.
  107. Wysokinski WE, Gosk-Bierska I, Karnicki K, McBane RD II. Etiology and natural history of venous thrombosis of atypical location. Phlebologie Annales Vasculaires. 2005; 58(3):322-401.
  108. Wysokinski WE, McBane RD 2nd. Images in vascular medicine. Fibromuscular dysplasia: an atypical cause of intermittent claudication. Vasc Med. 2004 Nov; 9: (4)315-7.
    View PubMed
  109. Wu LA, Spittell PC, Wysokinski WE, Miller FA Jr. Images in vascular medicine. Homogeneous aortic thickening seen on transesophageal echocardiography in a patient with giant cell arteritis. Vasc Med. 2004 Nov; 9: (4)319-20.
    View PubMed
  110. Wysokinski WE, Owen WG, Fass DN, Patrzalek DD, Murphy L, McBane RD 2nd. Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi. J Thromb Haemost. 2004 Sep; 2(9):1637-44.
    View PubMed
  111. Gosk-Bierska I, Karnicki K, Wysokinski W. [Role of tissue factor in thrombotic complications]. Pol Arch Med Wewn. 2004 Aug; 112: (2)969-73.
    View PubMed
  112. Maslowski L, McBane RD, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in Thromboangiitis Obliterans. Vascular Medicine. 2003; 7:253-9.
  113. Gosk-Bierska I, Adamiec R, Wysokinski WE. Effect of obesity on vascular complications in type 2 diabetes mellitus. Diabetol Pol. 2003; 10:386-90.
  114. Garg I, Camp JJ, McBane RD, Wysokinski W, Robb RA. Registration, segmentation and visualization of confocal microscopy images of arterial thrombus. Proc SPIE. 2003; 5367:628-635.
  115. Maslowski L, McBane R, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med. 2002 Nov; 7(4):259-64.
    View PubMed
  116. Gosk-Bierska I, Adamiec R, Alexewicz P, Wysokinski WE. Coagulation in diabetic and non-diabetic claudicants. Int Angiol. 2002 Jun; 21(2):128-33.
    View PubMed
  117. Sutkowska E, Drozd-Dworak I, Sutkowski K, Wysokinski WE. Assessment of perioperative cardiac risk in patients undergoing vascular surgery. Polish Archives of Internal Medicine CVIII. 2002; 2(8):817-25.
  118. Sutkowska E, Dabrowska G, Dziubek V, Wysokinski W. [Treadmill test for the assessment walking capacity of the patients with peripheral arterial occlusive disease]. Pol Arch Med Wewn. 2001 Jun; 105(6):525-31.
    View PubMed
  119. Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B, Doskocz B, Czarnacki M, Kowal-Gierczak B. Sustained classic clinical spectrum of Thromboangiitis Obliterans (Buerger's Disease). Angiology. 2000; 51(2):141-50.
    View PubMed
  120. Knapik-Kordecka M, Wysokinski WE. Clinical spectrum of Raynaud's phenomenon in patients referred to vascular clinic. Cardiovascular Surgery. 2000; 8(6):457-62.
    View PubMed
  121. Dziubek V, Dabrowska G, Drozd-Dworak I, Wysokinski WE. The effect of relaxation on selected hemodynamic parameters in the patients with arterial hypertension. Fizjoterapia. 2000; 8(2):46-50.
  122. Siemieniecka J, Dabrowska G, Wysokinski WE. The role of physical therapy in the patients after heart transplantation. Fizjoterapia. 2000; 8(3):11-5.
  123. Krysiak I, Wysokinski WE. Diet in the primary and secondary prophylaxis of cardiovascular diseases. Fizjoterapia. 2000; 8(3):25-9.
  124. Wysokinski WE, McBane RD 2nd, Owen WG. Individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol. 1999 Apr; 19(4):883-6.
    View PubMed
  125. Wysokinski WE. Hirudin - re-appreciated old anticoagulant with a great potential for future. Spraw Wrocl Tow Nauk. 1999; 1(52):7-22.
  126. Wysokinski WE. Guidelines for the treatment of deep vein thrombosis. In Venous Thromboembolic Disease Wroclaw. 1999:pp. 16-20.
  127. Wysokinski WE, Spittell PC, Pellikka PA, Miller WL, Seward JB. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation? Int Angiol. 1998 Sep; 17(3):201-7.
    View PubMed
  128. Wysokinski WE, Kwiatkowska W, Maslowski L, Witkiewicz W, Kowal-Gierczak B. Buerger's disease in two brothers. Iliac artery occlusion by thromboangiitis obliterans. Angiology. 1998; 49(5):409-14.
    View PubMed
  129. McBane RD, Wysokinski WE. Venous thromboembolism - new insights into treatment. Adv Clin Exp Med. 1998; 7(3):355-9.
  130. McBane RD, Wysokinski WE, Heit JA. Highly thrombogenic coronary lesions treated with IIb/IIIa receptor blocker. Adv Clinic Exp Med. 1998; 7(3):349-54.
  131. Wysokinski WE. Hirudins - a new generation of anticoagulants. Current achievements and unresolved problems. Acta Angiologica. 1997; 3(1):5-11.
  132. Wysokinski W, McBane R, Chesebro JH, Owen WG. Reversibility of platelet thrombosis in vivo. Quantitative analysis in porcine carotid arteries. Thromb Haemost. 1996 Dec; 76(6):1108-13.
    View PubMed
  133. Wysokinski WE, Kowal-Gierczak B. Aortic dissection. Part I: Ethiology, epidemiology and diagnosis. Acta Angiologica. 1996; 2(1):3-10.
  134. Wysokinski WE, Kowal-Gierczak B. Aortic dissection. Part II: Classification, clinical manifestation and therapy. Acta Angiologica. 1996; 2(2):103-8.
  135. McBane RD, Wysokinski WE, Chesebro JH, Owen WG. Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation. Thromb Haemost. 1995 Sep; 74(3):879-85.
    View PubMed
  136. Owen WG, Bichler J, Ericson D, Wysokinski W. Gating of thrombin in platelet aggregates by pO2-linked lowering of extracellular Ca2+ concentration. Biochemistry. 1995 Jul 25; 34 (29):9277-81
    View PubMed
  137. Wysokinski WE. Advanced peripheral vascular interventions 1995. Polish Heart Journal. 1995; XLIII(8):174-6.
  138. Wysokinski WE. Dethrombosis of arterial thrombus. Role of thrombin in cohesiveness of platelet reach thrombus. University Medical School of Wroclaw Wroclaw. 1995.
  139. Poniewierka E, Maslowski L, Wysokinski W, Lubczynska-Kowalska, Ciosek W. Neutrophil elastase activity in the patients with ulcerative colitis. Wiadomosci Lekarskie. 1994; XLVII(3-4):81-3.
  140. Wysokinski W, Beyens G, Blockmans D, Verhaeghe R. Assessment of the patency of deep leg veins with duplex. International Angiology. 1991; 10:69-71.
    View PubMed
  141. Wysokinski W, Verhaeghe R, Arnout J, Vermylen J. Protein C deficiency associated with venous thromboembolism. Acta Clinica Belgica. 1990; 45(2):78-84.
    View PubMed
  142. Wysokinski W. Peripheral necrosis of hind legs of rabbits immunized with elastin. VASA. 1989; 27:73-8.
  143. Szuba A, Wysokinski W. Apolipoprotein B - characteristics, physiology and clinical significance. Spraw Wrocl Tow Nauk. 1988; 43B:14-21.
  144. Kowal-Gierczak B, Lubczynska-Kowalska W, Markowska A, Pyra M, Wysokinski W, Maslowski L, Rybak M, Poniewierka E. The couses of death in elderly people based on clinical and autopsy report analysis. Prace Naukowe AM XIX. 1987; 1(44):333-40.
  145. Wysokinski W. Elastin metabolism and aging. Prace Naukowe AM XIX. 1987; 1(44):227-33.
  146. Kowal-Gierczak B, Knapik-Kordecka M, Lubczynska-Kowalska W, Wysokinski W, Maslowski L, Rybak M, Poniewierka E, Markowska A, Pyra M. Cardiovascular polypathy as a cause of death in elderly. Wiadomosci Lekarskie. 1987; 40(7):440-7.
    View PubMed
  147. Kowal-Gierczak B, Knapik-Kordecka M, Wysokinski W. Thromboangiitis obliterans and collagenoses. Polish Heart Journal. 1987; XXX(4):233-7.
  148. Knapik-Kordecka M, Kowal-Gierczak B, Wysokinski W. Some immunological aspects of chronic limb ischemia. Polish Heart Journal. 1987; XXX(4):242-8.
  149. Kowal-Gierczak B, Kurzawska-Mielecka M, Wysokinski W. Treatment of peripheral vascular diseases - clinical experience. Materia Medica Polona (1):24-28. 1986; 1986: 18.
  150. Wysokinski W, Rabczynski J. Late changes in rabbit's aortic wall after immunization with dissolved elastin. Spraw Wrocl Tow Nauk. 1986; 41B:16-8.
  151. Wysokinski W, Szuba A. Evaluation of antithrombin III, α2-macroglobulin and α1-antitrypsin in peripheral arterial occlusive disease. Prace Naukowe AM. 1984; XVII(1):137-44.
  152. Kowal-Gierczak B, Plamieniak L, Janukowicz-Lorenz H, Knapik-Kordecka M, Wysokinski W, Maslowski L. Clinic of peripheral arterial occlusive disease in elderly women. Prace Naukowe AM. 1984; XVII(1):161-5.
  153. Kurzawska-Mielecka M, Czarnacki M, Glanowski J, Janukowicz-Lorenz H, Kolasinska T, Knapik-Kordecka M, Kotschy M, Kowal-Gierczak B, Maslowski L Plamieniak L, Wlodarczyk K, Wysokinski W, Rychlik-Golema W, Szczygielski J. Lower limbs pain in arterial insufficiency of "Turow" coal mine workers. Prace Naukowe AM. 1984; XVII(1):217-28.
  154. Plamieniak L, Czarnacki M, Glanowski J, Janukowicz-Lorenz H, Kolasinska T, Knapik-Kordecka M, Kotschy M, Kowal-Gierczak B, Kurzawska-Mielecka M, Maslowski L, Rychlik-Golema W, Szczygielski J, Wlodarczyk K, Wysokinski W. Varicose veins in "Turow" coal mine workers. Prace Naukowe AM. 1984; XVII(1):253-8.
  155. Wysokinski W, Maslowski L. Doppler segmental blood pressure measurement for the evaluation of peripheral circulation. Spraw Wrocl Tow Nauk. 1984; 39b:91-100.